Curated News
By: NewsRamp Editorial Staff
April 12, 2024
Cardio Diagnostics Expands Access to Cardiovascular Tests Through Groundbreaking Telehealth Agreement
Discuss on Reddit
Discuss on SubstackTLDR
- Cardio Diagnostics' new deal with Navierre expands access to industry-leading precision cardiovascular tests, giving the company a competitive advantage in the growing cardiovascular diagnostics market.
- The partnership with Navierre aims to make Cardio Diagnostics' AI-enabled precision cardiovascular diagnostic tests more widely available, enabling clinicians to seamlessly order tests for their patients.
- This partnership makes Cardio Diagnostics' industry-leading cardiovascular clinical tests more accessible, democratizing access to top-tier heart disease services and addressing health equity and access.
- The AI healthcare market is expected to accelerate at a CAGR of 36.4%, indicating significant growth potential in the field of AI-driven precision diagnostics.
Impact - Why it Matters
The partnership between Cardio Diagnostics and Navierre is important as it revolutionizes the patient cardiovascular care journey through earlier detection, accessible specialty care, and personalized prevention. This collaboration directly responds to current diagnostic methods' limitations, offering a scalable solution that extends to remote zip codes in the U.S. The shift to digital health and AI-driven diagnostics could have a broad impact on the cardiovascular detection, care, and management industry, offering a response to the goal of combating cardiovascular diseases globally while committing to health equity and access.
Summary
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) has partnered with Navierre, a digital health technology platform, to expand access to its AI-enabled precision cardiovascular diagnostic tests. The partnership aims to make Cardio Diagnostics' tests more widely available to patients and clinicians nationwide. The company's flagship AI-powered epigenetic-genetic cardiovascular risk, detection, and management tests are now accessible to thousands of patients and clinicians on Navierre's platform, allowing consumers to easily register for a test. This strategic partnership leverages the growing telehealth market and revolutionizes the patient cardiovascular care journey through earlier detection, accessible specialty care, and personalized prevention.
Source Statement
This curated news summary relied on this press release disributed by News Direct. Read the source press release here, Cardio Diagnostics Expands Access to Cardiovascular Tests Through Groundbreaking Telehealth Agreement
